Since the beginning of 2009, VC investors have completed 464 deals involving U.K.-based healthcare companies, according to the PitchBook Platform. From 2009 to 2012, the number of deals completed each quarter increased, going from 71 in 2009 to 102 in 2012. Though 2013 saw a dip in completed deals (90) compared to the year prior, total capital invested in U.K. healthcare companies in 2013 ($486 million) actually increased from 2012 ($473 million).
During the timeframe, the U.K.'s pharmaceuticals & biotechnology sector has taken in the largest portion of the deal flow, accounting for 47% of completed healthcare deals. The U.K. healthcare sectors that follow are devices & supplies (39%), technology systems (7%) and services (7%). Some of the largest VC healthcare deals in the U.K. since 2009 include Optegra ($60 million, 2009), Nucana Biomed ($57 million, 2014), Cellnovo ($49 million, 2011) and Oxford Nanopore Technologies ($64 million, 2013).